483
Haisco-USA Pharmaceuticals, Inc.FDA 483 - Haisco-USA Pharmaceuticals, Inc. - October 09, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Haisco-USA Pharmaceuticals, Inc. in Bridgewater, NJ, revealed a significant failure in clinical study monitoring. The firm did not ensure adequate oversight by its contract research organization (CRO), leading to the enrollment of subjects who did not meet protocol-specified inclusion/exclusion criteria. This indicates a serious lapse in data verification and adherence to the investigational plan.
- Person
Open in Dashboard
ID · b7045a88-7da6-43ae-bbae-ec5d8683ce56